Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates (ADCs) from its oncology pipeline are presented at the American Association for Cancer Research (AACR) Annual Meetin

Related Keywords

Innovent Biologics , , Bispecific Antibodies , Presentation Form , Poster Section , Nc , Egfr , Abstract Number , Solid Tumors , Safety Profile , Innovent ,